Breaking News Instant updates and real-time market news.

BA

Boeing

$157.03

-0.45 (-0.29%)

, NOC

Northrop Grumman

$233.27

0.12 (0.05%)

12:01
12/22/16
12/22
12:01
12/22/16
12:01

Trump calls for 'greatly' strengthened, expanded nuclear capability

President-elect Donald Trump said via Twitter, "The United States must greatly strengthen and expand its nuclear capability until such time as the world comes to its senses regarding nukes." Publicly traded companies in the Defense space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX).

BA

Boeing

$157.03

-0.45 (-0.29%)

NOC

Northrop Grumman

$233.27

0.12 (0.05%)

UTX

United Technologies

$109.78

-0.71 (-0.64%)

BAESY

BAE Systems

$29.38

-0.23 (-0.78%)

GD

General Dynamics

$174.54

0.435 (0.25%)

LMT

Lockheed Martin

$251.95

-0.569 (-0.23%)

RTN

Raytheon

$143.01

0.45 (0.32%)

  • 25

    Jan

BA Boeing
$157.03

-0.45 (-0.29%)

12/13/16
MSCO
12/13/16
NO CHANGE
Target $185
MSCO
Overweight
Boeing raised its price target to $185 from $155 at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani raised Boeing's price target to $185 following the 30% increase to the dividend. The analyst believes the 30% raise demonstrates the Board's confidence in the cash flow story and addresses investor concerns regarding growth, sustainability, and accounting. Lalwani rates Boeing an Overweight.
12/21/16
GHSC
12/21/16
INITIATION
Target $180
GHSC
Buy
Boeing initiated with a Buy at Seaport Global
Seaport Global analyst Josh Sullivan initiated Boeing with a Buy and an $180 price target citing $400B+ in cash flow from the backlog and expectations for increased cash returns to shareholders.
12/21/16
12/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with a Buy at Seaport Global. 2. Qualcomm (QCOM) and NXP Semiconductors (NXPI) were initiated with a Neutral at Citi. 3. Mobileye (MBLY) was initiated with a Market Perform at BMO Capital and a Neutral at Susquehanna. 4. Ford (F) initiated with a Market Perform at BMO Capital. 5. Autoliv (ALV) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/16
VERT
12/22/16
NO CHANGE
VERT
Boeing take profits at current levels, says Vertical Research
Vertical Research analyst Robert Stallard said shares of Boeing have caught up to the S&P 500 for 2016 since the election. Stallard lowered earnings estimates to account for the latest 777 production cuts and said the airline outlook is easing. The analyst sees risk to the downside Boeing shares and recommends taking profits at current levels.
NOC Northrop Grumman
$233.27

0.12 (0.05%)

11/10/16
11/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Priceline (PCLN) upgraded to Buy from Hold at Stifel while the firm upgraded Expedia (EXPE) to Hold from Sell. 2. IBM (IBM) upgraded to Buy from Neutral at BofA/Merrill with analyst Wamsi Mohan expecting 2017 profits to grow as earnings have stabilized and negative revisions are unlikely and expects tailwinds from moderating pace of investments and savings from restructuring efforts. 3. L-3 Communications (LLL) and Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Barclays while the firm upgraded Lockheed Martin (LMT) to Equal Weight from Underweight. 4. Microsoft (MSFT) upgraded to Neutral from Underweight at Atlantic Equities. 5. Novartis (NVS) upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/16
LEHM
11/10/16
UPGRADE
Target $270
LEHM
Overweight
Northrop Grumman upgraded to Overweight on Trump's victory at Barclays
As previously reported, Barclays upgraded Northrop Gruman to Overweight from Equal Weight and raised its price target to $270 from $230. Analyst Carter Copeland upgraded his stance on the US Aerospace & Defense sector to Positive from Neutral and said he thinks the market will assign a 100% likelihood of higher near-term defense spending under a Trump administration.
11/10/16
LEHM
11/10/16
UPGRADE
LEHM
Overweight
Northrop Grumman upgraded to Overweight from Equal Weight at Barclays
12/21/16
DBAB
12/21/16
NO CHANGE
DBAB
Deutsche still bullish on U.S. Defense after channel checks
Deutsche Bank analyst Myles Walton left meetings with Department of Defense customer stakeholders confident in his bullish stance on U.S. Defense. The changing landscape in Washington D.C. favors defense, despite President-elect Trump's tweeting, Walton tells investors in a research note. His top names in the space are Lockheed Martin (LMT), Northrop Grumman (NOC), L-3 Communications (LLL), Huntington Ingalls (HII) and Orbital ATK (OA).
UTX United Technologies
$109.78

-0.71 (-0.64%)

12/18/16
FBCO
12/18/16
UPGRADE
FBCO
Outperform
United Technologies upgraded to Outperform from Neutral at Credit Suisse
12/13/16
WELS
12/13/16
NO CHANGE
WELS
Defense stock weakness creates buying opportunity, says Wells Fargo
Wells Fargo says that the decline in defense stocks following tweets by President-elect Trump criticizing the costs of the Air Force One and F-35 planes was overdone The firm says that interest rates have risen 50 basis points since the election, boosting the companies' ability to pay their pensions, while the defense budgets look poised to increase in the wake of the election results. However, several large cap defense stocks are little changed since before the election, Wells notes.. The firm adds that Lockheed Martin's margins on the F-35 remain strong, while the Trump administration would not be able to impact the program"for some time." It keeps Outperform ratings on Lockheed, General Dynamics (GD), Raytheon (RTN), United Technologies (UTX), and Orbital (OA).
12/19/16
12/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) and Bayer (BAYRY) were upgraded to Buy from Hold at Jefferies. 2. Costco (COST) upgraded to Buy from Neutral at Citi with analyst Kate McShane saying she sees a "clear path" to accelerating same-store-sales growth in fiscal 2017 as gasoline price deflation headwinds abate and benefits arise from the new co-branded credit card. 3. United Technologies (UTX) upgraded to Outperform from Neutral at Credit Suisse with analyst Julian Mitchell saying he believes consensus estimates are poised to move higher after years of heavy investment spending drive an earnings recovery. 4. ASML (ASML) upgraded to Buy from Neutral at BofA/Merrill with analyst Kai Korschelt saying a recent expert's call indicates progress with Extreme Ultraviolet/EUV lightsource optics & ecosystem and sees improving volume visibility from 2018 forward. 5. Gulfport Energy (GPOR) upgraded to Buy from Neutral at Guggenheim and to Overweight from Equal Weight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/16
FBCO
12/19/16
UPGRADE
Target $125
FBCO
Outperform
United Technologies upgraded to Outperform on earnings momentum at Credit Suisse
As previously reported, Credit Suisse upgraded United Technologies to Outperform from Neutral and raised its price target to $125 from $108. Analyst Julian Mitchell believes consensus estimates are poised to move higher after years of heavy investment spending drive an earnings recovery. Mitchell expects Aerospace headwinds to begin to abet in 2018, which should drive an earnings re-acceleration and believes Commercial business pressures in China and Europe are unlikely to intensify.
BAESY BAE Systems
$29.38

-0.23 (-0.78%)

12/15/16
JEFF
12/15/16
DOWNGRADE
JEFF
Hold
BAE Systems downgraded to Hold from Buy at Jefferies
Jefferies analyst Sandy Morris downgraded BAE Systems to Hold with a price target of GBP 600. The analyst does not expect the rise in defense spending to impact the company's near-term earnings.
06/27/16
BERN
06/27/16
NO CHANGE
BERN
BAE Systems has reached attractive entry point, says Bernstein
Bernstein says that the nearly 5% retreat in BAE Systems' stock on Friday was overdone. The firm says that the company has low exposure to the EU and should benefit from the decline of the British pound. It keeps an Outperform rating on the shares.
08/02/16
FBCO
08/02/16
DOWNGRADE
FBCO
Neutral
BAE Systems downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Olivier Brochet downgraded BAE Systems to Neutral citing valuation.
06/28/16
DBAB
06/28/16
UPGRADE
DBAB
Buy
BAE Systems upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded BAE Systems to Buy citing the recent pullback in the shares.
GD General Dynamics
$174.54

0.435 (0.25%)

10/28/16
10/28/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. L-3 Communications (LLL) initiated with an Outperform at Baird and a Hold at Vertical Research. 2. Twilio (TWLO) initiated with a Neutral at MUFG. 3. Cotiviti Holdings (COTV) assumed with an Overweight at JPMorgan. 4. Raytheon (RTN) and General Dynamics (GD) were initiated with a Buy at Vertical Research while the firm initiated Boeing (BA) and Northrop Grumman (NOC) with a Hold. 5. Allscripts (MDRX) assumed with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/01/16
BARD
12/01/16
NO CHANGE
Target $215
BARD
Outperform
General Dynamics price target raised to $215 from $181 at Baird
Baird analyst Peter Arment raised his price target on General Dynamics to $215 from $181 as he forecast a return to growth in 2018 for all four business segments of the company. He believes investors should continue to buy shares aggressively at current levels despite its recent gains. Arment reiterated his Outperform rating on General Dynamics shares.
11/28/16
COWN
11/28/16
NO CHANGE
Target $207
COWN
Outperform
General Dynamics price target raised to $207 from $176 at Cowen
Cowen analyst Cai von Rumohr raised his price target on General Dynamics to $207 from $176 and called it his top pick for 2017 as positive from the Trump election win bolster its already attractive prospects. The analyst likes its growth prospects and expects valuation to reset back into line with defense peers. He adds that business jet visibility has improved, also offering upside. The analyst reiterated his Outperform rating on General Dynamics shares.
LMT Lockheed Martin
$251.95

-0.569 (-0.23%)

11/14/16
STFL
11/14/16
UPGRADE
STFL
Buy
Lockheed Martin upgraded on 2018 outlook, election at Stifel
As noted earlier, Stifel upgraded Lockheed Martin to Buy from Hold. Analyst Joseph DeNardi is pleased with the company's comments regarding its 2018 free cash flow outlook, and he thinks that it could benefit from increased defense spending in the wake of the election results. Price target to $290 from $260.
11/14/16
11/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he is pleased with the company's comments regarding its 2018 free cash flow outlook, and he thinks that it could benefit from increased defense spending in the wake of the election results. 2. Philip Morris (PM) upgraded to Buy from Outperform at CLSA with analyst Michael Levy citing the recent pullback for his rating change and said he sees the company adding to its buyback. 3. Citi (C) upgraded to Overweight from Equal Weight at Morgan Stanley with analysts led by Betsy Graseck saying the Republican sweep is positive for all financial stocks due to increased growth, higher rates, lower taxes, and less regulation. 4. U.S. Steel (X) and AK Steel (AKS) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. L Brands (LB), Kohl's (KSS), and Chico's(CHS) were upgraded to Buy from Neutral at Citi, while Chico's was also upgraded to Outperform from Peer Perform at Wolfe Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RTN Raytheon
$143.01

0.45 (0.32%)

10/28/16
BARD
10/28/16
NO CHANGE
Target $170
BARD
Outperform
Raytheon weakness a buying opportunity, says Baird
Baird analyst Peter Arment said the weakness in Raytheon is a buying opportunity as the long-term growth thesis remains intact. The analyst remains bullish on the tailwinds impacting the company's programs on a global basis. Arment reiterated his Outperform rating and $170 price target on Raytheon shares.
10/28/16
VERT
10/28/16
INITIATION
Target $154
VERT
Buy
Raytheon initiated with a Buy at Vertical Research
Vertical Research analyst Robert Stallard initiated Raytheon with a Buy and a $154 price target.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.